85 related articles for article (PubMed ID: 7871910)
1. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
2. Relations between various DNA-parameters and degree of malignancy in endometrial carcinoma.
Naumann G; Köhler U; Nenning H; Emmert C; Taubert G; Bilek K
Arch Gynecol Obstet; 1996; 258(3):113-7. PubMed ID: 8781698
[TBL] [Abstract][Full Text] [Related]
3. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
Köhler U; Krug H; Taubert G
Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
[TBL] [Abstract][Full Text] [Related]
4. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
6. heterogeneity of dna ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatment.
Libalova P; Vernerova Z; Hubickova-Heringova L; Pinterova D; Kolostova K; Bobek V; Tikovsky K; Housa D; Kubecova M; Pecen L; Svoboda B
In Vivo; 2012; 26(3):473-80. PubMed ID: 22523302
[TBL] [Abstract][Full Text] [Related]
7. DNA content in malignant salivary gland tumours.
Monteiro LS; Palmeira C; Bento MJ; Lopes C
Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
9. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis].
Köhler U; Horn LG; Naumann G; Nenning H; Bilek K
Zentralbl Gynakol; 1995; 117(4):213-6. PubMed ID: 7778358
[TBL] [Abstract][Full Text] [Related]
10. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of DNA measurements in endometrial carcinoma.
Moberger B; Auer G; Forsslund G; Moberger G
Cytometry; 1984 Jul; 5(4):430-6. PubMed ID: 6468182
[TBL] [Abstract][Full Text] [Related]
13. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
14. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
Xue F; Jiao S; Zhao F
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
16. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
17. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in bladder cancer].
Matveev BP; Bogatyrev VN; Ermilova VD; Figurin KM; Mustia AI; Iurasova IV; Ataev AA
Urol Nefrol (Mosk); 1994; (5):43-5. PubMed ID: 7871623
[TBL] [Abstract][Full Text] [Related]
19. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurement of DNA content in gastric carcinoma; flow cytometry and video image analysis.
Brito MJ; Rosa JC; Thomas VA; Filipe MI
Anal Cell Pathol; 1994 Jul; 7(1):1-9. PubMed ID: 7981132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
